Company Information
SAN DIEGO, CA, 92130


DUNS: 831270843

# of Employees: 0

Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N

Award Charts

Award Listing

  1. Validation and development of specific small molecule inhibitors of HTRA1 for tre

    Amount: $249,411.00

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the most common cause of visual impairment of the elderly in developed countries. Despite its prevalence with the aging p ...

    SBIRPhase I2010Department of Health and Human Services
  2. iPS cell enabled therapy for geographic atrophy

    Amount: $203,852.00

    DESCRIPTION (provided by applicant): One specific focus and expertise of CalCyte Therapeutics Inc. is to develop and apply small molecule driven (i.e. chemically defined), stem cell based therapy to t ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government